Rethink Scientific Sourcing Strategy
Using Co-Creation to Free Resources for Product DevelopmentCase Study
A leading global consumer products company asked ATL to collaborate with them on how to build and strengthen their innovation pipeline. In order to do this, we evaluated their current business demands, resource allocations and short-term efforts. Working closely with company leaders, we discovered the need to shift from a narrow focus on compliance and data to a more comprehensive, long-term vision that incorporated innovative R&D strategies.
Action
Through a series of collective brainstorming sessions including a capabilities analysis and in-depth needs assessment, ATL designed a solution to reduce costs, streamline operations, reallocate company resources, and ensure the quality and integrity of the science remained intact. As a result, the company implemented our solution and relocated a majority of their data generated processes, more than 20,000 samples and data points, from their facility to ATL’s corporate laboratory.
Results
By partnering with ATL, this global organization was able to:
- Utilize ATL’s laboratory space and associates to execute their compliance and data responsibilities and safeguard the on-time, quality parameters critical to their business continuity
- Reallocate the time and energy saved on revenue-generating innovation and capitalize on getting to market faster
- Lower their overhead and facility costs
ATL is pleased to announce our relocation to a newly constructed, state of the art laboratory facility in Cincinnati, OH—marking our first major expansion since joining the Bureau Veritas family. This move represents a significant advancement for our organization and reinforces our commitment to delivering high quality service and technical excellence to our clients.
Our new facility features six additional stability chambers, enabling the launch of an expanded stability program. We have modernized our primary laboratory spaces to support a wide range of bioburden assays, including sterility testing, USP methods, and custom client protocols. In addition, we have enhanced our capabilities in preservative efficacy testing and challenge studies, strengthening the breadth of services we can provide.
This move is more than a change of address—it’s a strategic investment in innovation, enhanced capability, and the future of ATL.